Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2YS34 | — |
administered expired vaccine of Havrix 720; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received HAV (Havrix 720) (batch number 2YS34, expiry date 02-MAR-2025) for prophylaxis. On 11-MAR-2025, the patient received Havrix 720. On 11-MAR-2025, an unknown time after receiving Havrix 720, the patient experienced expired vaccine used (Verbatim: administered expired vaccine of Havrix 720). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 11-MAR-2025 The registered pharmacist reported that they had a nurse who administer a dose of Havrix 720 unit to a patient on the day of reporting that was expired which led to, expired vaccine used. The vaccine administration facility was the same as primary reporter.